Harvard Medical School Adviser: More options for treating pancreatic cancer Detroit Free Press They are sunitinib (Sutent) and everolimus (Afinitor). These new drugs disrupt molecular-level signaling within cancerous cells. They work in a much more targeted way than conventional chemotherapy. Cancer specialists see these two new drugs and drugs ... |
